The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group
| Image |  |
|---|---|
| Description | article |
| Author/s |
author: Douglas S Hawkins Suman Malempati William H. Meyer Torunn I Yock James R. Anderson |
| Publication date | October 23, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |